SEAPORT THERAPEUTICS

commercialization, namely, commercial consultancy in the pharmaceutical and biotechnology fields

House mark for pharmaceutical compositions as prophylaxis, diagnostics or treatments for human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases and drug delivery agents and formulations consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals and other chemical, synthetic or biologic payloads, in the nature of pharmaceutical compositions to treat the above disorders that can be administered in a range of approaches

research and development in the pharmaceutical, biotechnology, and digital medicine fields